Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Definitive Healthcare Corp. (DH)

1.1200 0.0000 (0.00%)
At close: October 30 at 4:00:01 PM EDT
1.1000 -0.0200 (-1.79%)
After hours: October 30 at 7:52:42 PM EDT
Chart Range Bar
Loading chart for DH
  • Previous Close 1.1200
  • Open 1.1400
  • Bid 1.1100 x 100
  • Ask 1.0900 x 100
  • Day's Range 1.0850 - 1.1400
  • 52 Week Range 0.6100 - 3.0000
  • Volume 447,913
  • Avg. Volume 629,012
  • Market Cap (intraday) 119.554M
  • Beta (5Y Monthly) 1.40
  • PE Ratio (TTM) --
  • EPS (TTM) -1.6100
  • Earnings Date (est.) Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 1.62
  • Motley Fool Rating Bearish

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

www.definitivehc.com

678

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DH
60.98%
S&P 500 (^GSPC)
10.73%

1-Year Return

DH
58.21%
S&P 500 (^GSPC)
11.11%

3-Year Return

DH
81.21%
S&P 500 (^GSPC)
81.91%

5-Year Return

DH
97.21%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 55.2M
Earnings -7.45M
Profit Margin -13.50%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-150M
-100M
-50M
0
50M
-300.0%
-200.0%
-100.0%

Analyst Insights

View More

Analyst Price Targets

1.00
1.62 Average
1.1200 Current
3.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/11/2026
Analyst Morgan Stanley
Rating Action Maintains
Rating Equal-Weight
Price Action Lowers
Price Target 2.5 -> 1.5

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -72.28%

  • Return on Assets (ttm)

    -1.94%

  • Return on Equity (ttm)

    -78.37%

  • Revenue (ttm)

    232.7M

  • Net Income Avi to Common (ttm)

    -168.2M

  • Diluted EPS (ttm)

    -1.6100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    183.8M

  • Total Debt/Equity (mrq)

    88.92%

  • Levered Free Cash Flow (ttm)

    50.35M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: